Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ ,e'r 0
D;sG9Hky
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© J;sQvPHV8
NSVE3
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© B4 bB`r
<*vR
_?!
1.Co-stimulators (or co-stimulating molecules) KKwM\
JCH9~n.
2.NK-kB NG3?OAQTw
G
1{m" 1M
3.Immunoglobulin superfamily SY9 5s
7a[6@
4.antigen-presenting cell (APC) BMq> Cj+
Q 1i5"'][
5.death domain 8B ,S_0!
IAA_Ft
6.CCR and CXCR ,wf_o%'eW
JbEEI(Q>g
7.Lectin (or mitogen) eNfH9l2k
!I|_vJ@<
8.Clusters of differentiation, CD) HRT
NIx
B<~AUf*y
9.B7 family qKSR5 #
#@nPB.
10.Cytotoxic T lymphocyte, CTL) dkC_Sh{
6l,6k~Z9
11.IL-15 and IL-15 receptor (IL-15R) I!b"Rv=Nf-
/1TK+E$
12.MHC restriction )4o8SF7lz
_I)TO_L;
13.Affinity-chromatography S%H"i
y
zvN7aG
14.Cyctosprin A, CsA Sj)?!
=Crl{Ax
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) J_a2DM6d
*s, bz.[
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© F.(W`H*1+
m,+E5^
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 },<Y
\
n[BYBg1yG
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ nzO-\`40
f:nXE&X[
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 @WXRZEz
<bn|ni|c"
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ;Ym6ey0t
H [M:iV
ÃâÒßѧרҵ£º 3 p -SpUvp
RYl{89
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ <`q-#-V@
JFu.o8[Q
Ïû»¯ÄÚ¿Æ£º
!#1UTa
(w_b
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ /2r&ga&
79Aa~ +i'_
ѪҺ²¡Ñ§×¨Òµ£º kQ[23
R4D$)D
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿